135 related articles for article (PubMed ID: 2451274)
1. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.
Garred P; Mollnes TE; Lea T
Scand J Immunol; 1988 Mar; 27(3):329-35. PubMed ID: 2451274
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
3. Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassay.
Mollnes TE; Lachmann PJ
J Immunol Methods; 1987 Aug; 101(2):201-7. PubMed ID: 2440954
[TBL] [Abstract][Full Text] [Related]
4. Enzyme immunoassay detection of circulating immune complexes by monoclonal antibodies to C3 neoepitopes with special reference to IgG concentration and to interfering anti-immunoglobulin antibodies.
Garred P; Mollnes TE; Lea T; Lachmann PJ
J Immunol Methods; 1989 Feb; 117(1):59-66. PubMed ID: 2464039
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.
Mollnes TE
Scand J Immunol; 1985 Jun; 21(6):607-13. PubMed ID: 3895396
[TBL] [Abstract][Full Text] [Related]
6. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitro.
Pettersen HB; Johnson E; Mollnes TE; Garred P
Scand J Immunol; 1988 Oct; 28(4):431-4. PubMed ID: 2461585
[TBL] [Abstract][Full Text] [Related]
9. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
10. Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3.
Palarasah Y; Skjodt K; Brandt J; Teisner B; Koch C; Vitved L; Skjoedt MO
J Immunol Methods; 2010 Oct; 362(1-2):142-50. PubMed ID: 20869965
[TBL] [Abstract][Full Text] [Related]
11. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with factor I deficiency and with autoimmune diseases.
Møller Rasmussen J; Jepsen HH; Teisner B; Holmskov-Nielsen U; Rasmussen GG; Svehag SE
Vox Sang; 1989; 56(4):262-9. PubMed ID: 2474900
[TBL] [Abstract][Full Text] [Related]
12. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
13. Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.
Holmskov-Nielsen U; Jensenius JC; Teisner B; Erb K
J Immunol Methods; 1986 Nov; 94(1-2):1-6. PubMed ID: 2431062
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.
Zilow G; Naser W; Rutz R; Burger R
J Immunol Methods; 1989 Jul; 121(2):261-8. PubMed ID: 2503562
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).
Mollnes TE; Redl H; Høgåsen K; Bengtsson A; Garred P; Speilberg L; Lea T; Oppermann M; Götze O; Schlag G
Clin Exp Immunol; 1993 Feb; 91(2):295-300. PubMed ID: 7679061
[TBL] [Abstract][Full Text] [Related]
16. A new method for the estimation of C3d. Affinity clearance of C-determinant-bearing C3 molecules and fragments followed by estimation of C3d by ELISA.
Asghar SS; Schraag B; Backhaus AH; Zorn I; Venneker GT; Hannema AJ
J Immunol Methods; 1989 Jun; 120(2):207-14. PubMed ID: 2472454
[TBL] [Abstract][Full Text] [Related]
17. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of assays detecting complement activation. Complement-split product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA).
Espersen GT; Langeland B; Grunnet N
Scand J Clin Lab Invest; 1990 Jun; 50(4):389-93. PubMed ID: 1697427
[TBL] [Abstract][Full Text] [Related]
19. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation.
Mollnes TE; Garred P; Bergseth G
Clin Exp Immunol; 1988 Sep; 73(3):484-8. PubMed ID: 2463123
[TBL] [Abstract][Full Text] [Related]
20. Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.
Kanayama Y; Kurata Y; McMillan R; Tamerius JD; Negoro N; Curd JG
J Immunol Methods; 1986 Apr; 88(1):33-6. PubMed ID: 2420896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
